3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?—A Scoping Review

por Lafeber, Iris, Ruijgrok, Elisabeth J., Guchelaar, Henk-Jan, Schimmel, Kirsten J. M.
Publicado 2022

Personalised drug repositioning for Clear Cell Renal Cell Carcinoma using gene expression

por Koudijs, Karel K. M., Terwisscha van Scheltinga, Anton G. T., Böhringer, Stefan, Schimmel, Kirsten J. M., Guchelaar, Henk-Jan
Publicado 2018

The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples

por Koudijs, Karel K. M., Terwisscha van Scheltinga, Anton G. T., Böhringer, Stefan, Schimmel, Kirsten J. M., Guchelaar, Henk-Jan
Publicado 2019

Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials

por Vrinten, Charlotte, Lipka, Alexander F, van Zwet, Erik W, Schimmel, Kirsten J M, Cornel, Martina C, Kuijpers, Marja R, Hekster, Yechiel A, Weinreich, Stephanie S, Verschuuren, Jan J G M
Publicado 2015

Aggregated N-of-1 trials for unlicensed medicines for small populations: an assessment of a trial with ephedrine for myasthenia gravis

por Weinreich, Stephanie S., Vrinten, Charlotte, Kuijpers, Marja R., Lipka, Alexander F., Schimmel, Kirsten J. M., van Zwet, Erik W., Gispen-de Wied, Christine, Hekster, Yechiel A., Verschuuren, Jan J. G. M., Cornel, Martina C.
Publicado 2017